# Safety and Performance of INVICTA Ventricular DF4 LEADS With Active Fixation-(APOLLO)

Study · id `cardio:ct-nct04590144` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04590144](<https://clinicaltrials.gov/study/NCT04590144>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04590144

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 446 participants.

## Technical summary

Registry record NCT04590144. Allocation not applicable; no masking; primary purpose treatment. Start 2021-06-04 (actual); primary completion 2022-03-16 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 446 participants (enrolled count; ClinicalTrials.gov record NCT04590144, source copy `cardio:ctgov-nct04590144-2025-07-24`, retrieved 2026-10-26)
- Started: 2021-06-04 (actual) (ClinicalTrials.gov record NCT04590144, source copy `cardio:ctgov-nct04590144-2025-07-24`, retrieved 2026-10-26)
- Primary completion: 2022-03-16 (actual) (ClinicalTrials.gov record NCT04590144, source copy `cardio:ctgov-nct04590144-2025-07-24`, retrieved 2026-10-26)
- Completion: 2024-12-23 (actual) (ClinicalTrials.gov record NCT04590144, source copy `cardio:ctgov-nct04590144-2025-07-24`, retrieved 2026-10-26)
- Countries: Austria; France; Germany; Italy; Netherlands; Portugal; Spain; United Kingdom (ClinicalTrials.gov record NCT04590144, source copy `cardio:ctgov-nct04590144-2025-07-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04590144-2025-07-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Performance of INVICTA Ventricular DF4 LEADS With Active Fixation-(APOLLO)
- Acronym: APOLLO
- Condition: Ventricular Arrythmia
- Condition: Lead
- Condition: ICD
- Condition: Heart Failure
- Intervention (Device): INVICTA lead
- Lead sponsor: MicroPort CRM
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: MicroPort CRM (`cardio:org-microport-crm`)

## Provenance

Content hash: 490e155c1292bd10b0cb1291627ea6b19c24db3abbd7f0c03fe49b09b7615746
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
